Dogwood Therapeutics, Inc. Cash and Restricted Cash
Dogwood Therapeutics, Inc. (DWTX) had Cash and Restricted Cash of $9.61 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.61M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.23M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.52M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.13M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $9.61M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $13.23M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $6.52M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $10.13M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $13.40M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $17.54M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $14.85M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $2.04M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $3.02M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $2.38M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $3.32M 10-K · filed 2026-03-18 |
| 2023-09-30 | $4.79M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $4.59M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $5.33M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $7.03M 10-K · filed 2025-03-31 |
| 2022-09-30 | $9.79M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $7.70M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $11.35M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $14.01M 10-K/A · filed 2024-03-08 |
| 2021-09-30 | $19.19M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $21.84M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $24.59M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $29.80M 10-K · filed 2023-03-14 |
| 2020-09-30 | $499.08K 10-Q · filed 2021-11-12 |
| 2020-06-30 | $1.05M 10-Q · filed 2021-08-13 |
| 2020-03-31 | $1.19M 10-Q · filed 2021-05-14 |
| 2019-12-31 | $309.38K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |